Maturation and persistence of CAR T cells derived from human pluripotent stem cells via chemical inhibition of G9a/GLP.

Saved in:
Bibliographic Details
Title: Maturation and persistence of CAR T cells derived from human pluripotent stem cells via chemical inhibition of G9a/GLP.
Authors: Jing R; Stem Cell Program, Boston Children's Hospital, Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA., Falchetti M; Stem Cell Program, Boston Children's Hospital, Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA., Han T; Stem Cell Program, Boston Children's Hospital, Boston, MA 02115, USA., Najia M; Stem Cell Program, Boston Children's Hospital, Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA., Hensch LT; Stem Cell Program, Boston Children's Hospital, Boston, MA 02115, USA., Meader E; Stem Cell Program, Boston Children's Hospital, Boston, MA 02115, USA., Lummertz da Rocha E; Department of Microbiology, Immunology and Parasitology, Federal University of Santa Catarina, Florianópolis, SC 88040-900, Brazil., Kononov M; Stem Cell Program, Boston Children's Hospital, Boston, MA 02115, USA., Wang S; Stem Cell Program, Boston Children's Hospital, Boston, MA 02115, USA., Bingham T; Stem Cell Program, Boston Children's Hospital, Boston, MA 02115, USA., Li Z; Stem Cell Program, Boston Children's Hospital, Boston, MA 02115, USA., Zhao Y; Stem Cell Program, Boston Children's Hospital, Boston, MA 02115, USA., Frenis K; Stem Cell Program, Boston Children's Hospital, Boston, MA 02115, USA., Kubaczka C; Stem Cell Program, Boston Children's Hospital, Boston, MA 02115, USA., Yang S; Stem Cell Program, Boston Children's Hospital, Boston, MA 02115, USA., Jha D; Stem Cell Program, Boston Children's Hospital, Boston, MA 02115, USA., Rodrigues-Luiz GF; Graduate Program of Pharmacology, Center for Biological Sciences, Federal University of Santa Catarina, Florianópolis, SC 88040-900, Brazil., Rowe RG; Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Boston, MA 02115, USA., Schlaeger TM; Stem Cell Program, Boston Children's Hospital, Boston, MA 02115, USA., Maus MV; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Charlestown, MA 02114, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA., North TE; Stem Cell Program, Boston Children's Hospital, Boston, MA 02115, USA; Developmental and Regenerative Biology Program, Harvard Medical School, Boston, MA 02115, USA., Zon LI; Stem Cell Program, Boston Children's Hospital, Boston, MA 02115, USA; Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115, USA., Daley GQ; Stem Cell Program, Boston Children's Hospital, Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA. Electronic address: george.daley@childrens.harvard.edu.
Source: Cell stem cell [Cell Stem Cell] 2025 Jan 02; Vol. 32 (1), pp. 71-85.e5. Date of Electronic Publication: 2024 Nov 05.
Publication Type: Journal Article
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101311472 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1875-9777 (Electronic) Linking ISSN: 18759777 NLM ISO Abbreviation: Cell Stem Cell Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1875-9777
DOI:10.1016/j.stem.2024.10.004